Market Segmentation Tab
Preclinical Imaging Fusion Reagent Outlook (USD Billion, 2018-2030)
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Preclinical Imaging Reagent Outlook (USD Billion, 2018-2030)
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Preclinical Imaging Regional Outlook (USD Billion, 2018-2030)
North America Outlook (USD Billion, 2018-2030)
North America Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
North America Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
US Outlook (USD Billion, 2018-2030)
US Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
US Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
CANADA Outlook (USD Billion, 2018-2030)
CANADA Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
CANADA Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Europe Outlook (USD Billion, 2018-2030)
Europe Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Europe Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Germany Outlook (USD Billion, 2018-2030)
Germany Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Germany Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
France Outlook (USD Billion, 2018-2030)
France Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
France Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
UK Outlook (USD Billion, 2018-2030)
UK Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
UK Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
ITALY Outlook (USD Billion, 2018-2030)
ITALY Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
ITALY Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
SPAIN Outlook (USD Billion, 2018-2030)
Spain Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Spain Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Rest Of Europe Outlook (USD Billion, 2018-2030)
Rest Of Europe Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
REST OF EUROPE Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Asia-Pacific Outlook (USD Billion, 2018-2030)
Asia-Pacific Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Asia-Pacific Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
China Outlook (USD Billion, 2018-2030)
China Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
China Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Japan Outlook (USD Billion, 2018-2030)
Japan Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Japan Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
India Outlook (USD Billion, 2018-2030)
India Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
India Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Australia Outlook (USD Billion, 2018-2030)
Australia Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Australia Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
Rest of Asia-Pacific Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Rest of Asia-Pacific Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Rest of the World Outlook (USD Billion, 2018-2030)
Rest of the World Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Rest of the World Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Middle East Outlook (USD Billion, 2018-2030)
Middle East Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Middle East Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Africa Outlook (USD Billion, 2018-2030)
Africa Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Africa Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Latin America Outlook (USD Billion, 2018-2030)
Latin America Preclinical Imaging by Fusion Reagent
Optical Imaging
Nuclear Imaging
Micro-MRI
Micro-Ultrasound
Micro-CT
Photoacoustic Imaging System
Latin America Preclinical Imaging by Reagent
Optical
Nuclear
CT Contrast Agents
MRI Contrast Agents
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
Chapter 3. Research Methodology
3.1. Introduction
3.2. Primary Research
3.3. Secondary Research
3.4. Market Reagent Estimation
Chapter 4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
4.4. Challenges
Chapter 5. Market Factor Analysis
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. Investment Feasibility Analysis
5.4. Pricing Analysis
Chapter 6. Global Preclinical Imaging Market, by Modality
6.1. Introduction
6.2. Optical Imaging Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.1. Bioluminescence/Fluorescence Imaging Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2. Standalone Fluorescence Imaging Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.3. Optical + X ray/ Optical + CT systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Nuclear Imaging Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.1. Micro-PET Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.2. Micro-Spect Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3.3. Trimodality (Spect/PET/CT) Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Micro-MRI
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Micro-Ultrasound
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.6. Micro-CT
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.7. Photoacoustic Imaging System
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.8. Magnetic Particle Imaging Systems
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 7. Global Preclinical Imaging Market, by Reagent
7.1. Introduction
7.2. Preclinical Optical Imaging Reagents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.1. Bioluminescent Imaging Reagents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2. Fluorescent Imaging Reagents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Preclinical Nuclear Imaging Reagents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.1. Preclinical PET Tracers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3.2. Preclinical Spect Probes
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Preclinical MRI Contrast Agents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.5. Preclinical Ultrasound Contrast Agents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.6. Preclinical CT Contrast Agents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
Chapter 8. Global Preclinical Imaging Market, by Region
8.1. Introduction
8.2. Americas
8.2.1. North America
8.2.1.1. US
8.2.1.2. Canada
8.2.2. Latin America
8.3. Europe
8.3.1. Western Europe
8.3.1.1. Germany
8.3.1.2. France
8.3.1.3. Italy
8.3.1.4. Spain
8.3.1.5. UK
8.3.1.6. Rest of Western Europe
8.3.2. Eastern Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle East & Africa
8.5.1. Middle East
8.5.2. Africa
Chapter 9. Company Landscape
9.1. Introduction
9.2. Market Share Analysis
Chapter 10. Company Profiles
10.1. Bruker Corporation
10.1.1. Company Overview
10.1.2. Modality Overview
10.1.3. Financials Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. MR Solutions
10.2.1. Company Overview
10.2.2. Modality Overview
10.2.3. Financials Overview
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. PerkinElmer Inc.
10.3.1. Company Overview
10.3.2. Modality Overview
10.3.3. Financials Overview
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Fujifilm Holdings Corporation
10.4.1. Company Overview
10.4.2. Modality Overview
10.4.3. Financials Overview
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Milabs B.V.
10.5.1. Company Overview
10.5.2. Modality Overview
10.5.3. Financials Overview
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Mediso Ltd.
10.6.1. Company Overview
10.6.2. Modality Overview
10.6.3. Financials Overview
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. LI-COR, Inc.
10.7.1. Company Overview
10.7.2. Modality Overview
10.7.3. Financials Overview
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Aspect Imaging
10.8.1. Company Overview
10.8.2. Modality Overview
10.8.3. Financials Overview
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Trifoil Imaging
10.9.1. Company Overview
10.9.2. Modality Overview
10.9.3. Financials Overview
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Miltenyi Biotec GmbH
10.10.1. Company Overview
10.10.2. Modality Overview
10.10.3. Financials Overview
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Others
Chapter 11. MRFR Conclusion
11.1. Key Findings
11.1.1. From CEO’s View point
11.1.2. Unmet Needs of the Market
11.2. Key Companies to Watch
11.3. Predictions for the Preclinical Imaging Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1. Global Preclinical Imaging Market Synopsis, 2020-2027
Table 2. Global Preclinical Imaging Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3. Global Preclinical Imaging Market, by Region, 2020-2027 (USD Million)
Table 4. Global Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 5. Global Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 6. North America: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 7. North America: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 8. US: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 9. US: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 10. Canada: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 11. Canada: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 12. Latin America: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 13. Latin America: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 14. Europe: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 15. Europe: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 16. Western Europe: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 17. Western Europe: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 18. Eastern Europe: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 19. Eastern Europe: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 20. Asia-Pacific: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 21. Asia-Pacific: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
Table 22. Middle East & Africa: Preclinical Imaging Market, by Modality, 2020-2027 (USD Million)
Table 23. Middle East & Africa: Preclinical Imaging Market, by Reagent, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1. Research Process
Figure 2. Segmentation for Global Preclinical Imaging Market
Figure 3. Market Dynamics for Global Preclinical Imaging Market
Figure 4. Global Preclinical Imaging Market Share, by Modality, 2020
Figure 5. Global Preclinical Imaging Market Share, by Reagent, 2020
Figure 6. Global Preclinical Imaging Market Share, by Region, 2020
Figure 7. North America: Preclinical Imaging Market Share, by Country, 2020
Figure 8. Europe: Preclinical Imaging Market Share, by Country, 2020
Figure 9. Asia-Pacific: Preclinical Imaging Market Share, by Country, 2020
Figure 10. Middle East & Africa: Preclinical Imaging Market Share, by Country, 2020
Figure 11. Global Preclinical Imaging Market: Company Share Analysis, 2020 (%)
Figure 12. Bruker Corporation: Key Financials
Figure 13. Bruker Corporation: Segmental Revenue
Figure 14. Bruker Corporation: Geographical Revenue
Figure 15. MR Solutions: Key Financials
Figure 16. MR Solutions: Segmental Revenue
Figure 17. MR Solutions: Geographical Revenue
Figure 18. PerkinElmer Inc.: Key Financials
Figure 19. PerkinElmer Inc.: Segmental Revenue
Figure 20. PerkinElmer Inc.: Geographical Revenue
Figure 21. Fujifilm Holdings Corporation: Key Financials
Figure 22. Fujifilm Holdings Corporation: Segmental Revenue
Figure 23. Fujifilm Holdings Corporation: Geographical Revenue
Figure 24. Milabs B.V.: Key Financials
Figure 25. Milabs B.V.: Segmental Revenue
Figure 26. Milabs B.V.: Geographical Revenue
Figure 27. Mediso Ltd.: Key Financials
Figure 28. Mediso Ltd.: Segmental Revenue
Figure 29. Mediso Ltd.: Geographical Revenue
Figure 30. LI-COR, Inc.: Key Financials
Figure 31. LI-COR, Inc.: Segmental Revenue
Figure 32. LI-COR, Inc.: Geographical Revenue
Figure 33. Aspect Imaging: Key Financials
Figure 34. Aspect Imaging: Segmental Revenue
Figure 35. Aspect Imaging: Geographical Revenue
Figure 36. Trifoil Imaging: Key Financials
Figure 37. Trifoil Imaging: Segmental Revenue
Figure 38. Trifoil Imaging: Geographical Revenue
Figure 39. Miltenyi Biotec GmbH: Key Financials
Figure 40. Miltenyi Biotec GmbH: Segmental Revenue
Figure 41. Miltenyi Biotec GmbH: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
